Application and Dosimetric Requirements for Gallium-68-labeled Somatostatin Analogues in Targeted Radionuclide Therapy for Gastroenteropancreatic Neuroendocrine Tumors

被引:13
作者
Taieb, David [1 ,2 ,3 ]
Garrigue, Philippe [4 ]
Bardies, Manuel [5 ]
Abdullah, Ahmad Esmaeel [1 ]
Pacak, Karel [6 ]
机构
[1] Aix Marseille Univ, La Timone Univ Hosp, Dept Nucl Med, F-13385 Marseille, France
[2] Aix Marseille Univ, European Ctr Res Med Imaging, Marseille, France
[3] INSERM, Marseille Cancerol Res Ctr, Inst Paoli Calmettes, Marseille, France
[4] Aix Marseille Univ, La Timone Univ Hosp, Dept Radiopharm, Marseille, France
[5] UPS, INSERM, Canc Res Ctr Toulouse, UMR 1037, Toulouse, France
[6] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Natl Inst Hlth, Program Reprod & Adult Endocrinol, Bethesda, MD 20892 USA
关键词
PET; Gallium radioisotopes; Somatostatin; Gastroenteropancreatic; Neuroendocrine;
D O I
10.1016/j.cpet.2015.06.001
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Theranostics of GEP-NETs based on 68Ga-labeled SSTa PET imaging and targeted therapy applying PRRT with 90Y-labeled and/or 177Lu-labeled SSTa has paved the way for personalized medicine ( Fig. 3). Future directions include the clinical use of somatostatin antagonists as targeting peptides for imaging and therapy47 and the development of novel receptor-targeting radiopharmaceuticals that hold promise for theranostics of NETs.
引用
收藏
页码:477 / 486
页数:10
相关论文
共 47 条
[1]   The genomic landscape of small intestine neuroendocrine tumors [J].
Banck, Michaela S. ;
Kanwar, Rahul ;
Kulkarni, Amit A. ;
Boora, Ganesh K. ;
Metge, Franziska ;
Kipp, Benjamin R. ;
Zhang, Lizhi ;
Thorland, Erik C. ;
Minn, Kay T. ;
Tentu, Ramesh ;
Eckloff, Bruce W. ;
Wieben, Eric D. ;
Wu, Yanhong ;
Cunningham, Julie M. ;
Nagorney, David M. ;
Gilbert, Judith A. ;
Ames, Matthew M. ;
Beutler, Andreas S. .
JOURNAL OF CLINICAL INVESTIGATION, 2013, 123 (06) :2502-2508
[2]  
Barone R, 2005, J NUCL MED, V46, p99S
[3]   'Reverse discordance' between 68Ga-DOTA-NOC PET/CT and 177Lu-DOTA-TATE posttherapy scan: the plausible explanations and its implications for high-dose therapy with radiolabeled somatostatin receptor analogs [J].
Basu, Sandip ;
Abhyankar, Amit ;
Kand, Purushottam ;
Kumar, Rakesh ;
Asopa, Ramesh ;
Rajan, Mysore Govinda Ramakrishna ;
Nayak, Uday ;
Shimpi, Hemant ;
Das, Tapas ;
Venkatesh, Meera ;
Chakrabarty, Sudipta ;
Banerjee, Sharmila .
NUCLEAR MEDICINE COMMUNICATIONS, 2011, 32 (07) :654-658
[4]   Peptides and Receptors in Image-Guided Therapy: Theranostics for Neuroendocrine Neoplasms [J].
Baum, Richard P. ;
Kulkarni, Harshad R. ;
Carreras, Cecilia .
SEMINARS IN NUCLEAR MEDICINE, 2012, 42 (03) :190-207
[5]   Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors [J].
Bodei, Lisa ;
Kidd, Mark ;
Paganelli, Giovanni ;
Grana, Chiara M. ;
Drozdov, Ignat ;
Cremonesi, Marta ;
Lepensky, Christopher ;
Kwekkeboom, Dik J. ;
Baum, Richard P. ;
Krenning, Eric P. ;
Modlin, Irvin M. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 (01) :5-19
[6]   Peptide Receptor Radionuclide Therapy for Advanced Neuroendocrine Tumors [J].
Bodei, Lisa ;
Cremonesi, Marta ;
Kidd, Mark ;
Grana, Chiara M. ;
Severi, Stefano ;
Modlin, Irvin M. ;
Paganelli, Giovanni .
THORACIC SURGERY CLINICS, 2014, 24 (03) :333-+
[7]   Peptide receptor radionuclide therapy with 177Lu-DOTATATE: the IEO phase I-II study [J].
Bodei, Lisa ;
Cremonesi, Marta ;
Grana, Chiara M. ;
Fazio, Nicola ;
Iodice, Simona ;
Baio, Silvia M. ;
Bartolomei, Mirco ;
Lombardo, Dario ;
Ferrari, Mahila E. ;
Sansovini, Maddalena ;
Chinol, Marco ;
Paganelli, Giovanni .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 (12) :2125-2135
[8]   Standardized Uptake Values of 68Ga-DOTANOC PET: A Promising Prognostic Tool in Neuroendocrine Tumors [J].
Campana, Davide ;
Ambrosini, Valentina ;
Pezzilli, Raffaele ;
Fanti, Stefano ;
Labate, Antonio Maria Morselli ;
Santini, Donatella ;
Ceccarelli, Claudio ;
Nori, Francesca ;
Franchi, Roberto ;
Corinaldesi, Roberto ;
Tomassetti, Paola .
JOURNAL OF NUCLEAR MEDICINE, 2010, 51 (03) :353-359
[9]  
Caplin ME, 2014, NEW ENGL J MED, V371, P224, DOI [10.1056/NEJMoa1316158, 10.1056/NEJMc1409757]
[10]  
Cremonesi M, 2011, Q J NUCL MED MOL IM, V55, P155